Innovations May 2025
Dr. Olivier Elemento discusses how AI is being used to fine-tune cancer research, and its potential to transform precision medicine and HIV science.
Can AI Help Piece Together the Puzzle of Cancer—and HIV?
New technology that more precisely analyzes patients’ biological data could deliver more effective, personalized treatment for people living with HIV.
Researchers Announce Two New Probable HIV Cure Cases
Shaping the Future of HIV Research
Unprecedented Cuts Across Health and Human Services Put Lives in Peril
Helping Youth Transition into Adult Care
Meet the New CEO
Kyle Clifford maps out his vision as he prepares to step into the leadership role.
amfAR Announces Chief Executive Officer Succession Plan
Kevin Robert Frost has announced he will retire at the end of the year, handing the reins to Chief Development Officer Kyle Clifford.
Leading the Way Forward
Dr. Andrea Gramatica, Karen Mateo, and Shawn Davidson join amfAR‘s management team.
Hope and Gratitude in Uncertain Times
amfAR CEO Kevin Robert Frost introduces the new issue of Innovations.
How NIH Funding Fuels Innovation and Economic Growth
amfAR argues that robust federal investment in biomedical research is essential both for protecting health and securing our economic future.
Learning from Post-Treatment Control
Groundbreaking amfAR immunotherapy trial yields new knowledge, new research.
HIV, HPV, and Cervical Cancer: A Deadly Nexus
New research aims to expand prevention and improve health outcome for women in Indonesia.
A Life Lived at Full Throttle
A kind, adventurous woman who loved many causes, Dorothea Lyman extended her long support of amfAR with a legacy gift upon her passing.
